Twenty-two patients (48%) had a decompensated cirrhosis; 27 (59%) had a history of hypertension, among them, 17 (37%) patients were treated by angiotensin-converting enzyme inhibitors or angiotensin receptor blockers before kidney biopsy. This evidence concerns the gene ACE and hypertensive disorder.